Interview with Jack Schalken. PCA3 and its Use as a Diagnostic Test in Prostate Cancer

European Urology

Volumn 50, Issue 1, 2006, Pages 153-154

  McKillop, Christine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROSTATE CANCER ANTIGEN 3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC TEST; DIFFERENTIAL DISPLAY; DIGITAL RECTAL EXAMINATION; GENE EXPRESSION; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; VALIDATION PROCESS;

EID: 33744907712     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.04.021     Document Type: Note

References (4)

1. Bussemakers M.J., van Bokhoven A., Verhaegh G.W., et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59 (1999) 5975-5979
2. Hessels D., Klein Gunnewiek J.M., van Oort I., et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44 (2003) 8-15
3. Tinzl M., Marberger M., Horvath S., and Chypre C. DD3PCA3 RNA analysis in urine - a new perspective for detecting prostate cancer. Eur Urol 46 (2004) 182-186
4. Fradet Y., Saad F., Aprikian A., et al. uPM3, a new molecular urine test for the detection of prostate cancer. Urology 64 (2004) 311-315